Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us

Defra announces new review of bovine TB priorities

PBD Biotech welcomes the news that Defra is to review its priorities for the next phase of its strategy for achieving Officially Bovine Tuberculosis Free (OTF) status in England by 2038.
  • February 19, 2018
  • Bovine TB
Professor Sir Charles Godfray

The review will be led and overseen by Professor Sir Charles Godfray, Director of the Oxford Martin Programme on the Future of Food at the University of Oxford. He will be supported by a small working group. The review is expected to begin in March and finish by the end of September 2018.

PBD Biotech has developed a new, rapid test for bovine TB, and other mycobacterial infections, that can identify live bacteria in blood or milk. The test, called Actiphage®, differs from all existing technology as it directly and rapidly detects the presence of live bacteria at an early stage of infection and would allow improved management of this disease which has destroyed herds and the livelihood of livestock farmers. It hopes that the review will consider new technologies such as Actiphage as part of a portfolio of measures to combat the disease.

The review’s terms of reference set out what it will look at and how it will be carried out.

The review will:

  • consider and advise on the opportunities for improved application, enhancement or acceleration of the interventions set out in the Strategy, including cattle vaccination, oral badger vaccination, improved genetic resistance and improved diagnostic tests, or to deploy new tools and/or technologies to fight the disease
  • consider how delivery is monitored and how impact of the Strategy is evaluated (and what that tells us about progress of the disease and the dynamics of its spread), and make recommendations as to whether and how these can be improved
  • advise on gaps in the available evidence and disease control tools. Recommend options to address these (including the application of epidemiology and research) to achieve the aims of the Strategy.
  • The Rt Hon Michael Gove, Secretary of State for Environment, Food and Rural Affairs comments in a letter that the aim of the review “is to identify what actions we could take now to ensure that other
  • elements of the strategy such as cattle vaccination or improved genetic resistance, are ready to deploy at later phases of the strategy.”

https://www.gov.uk/government/publications/a-strategy-for-achieving-bovine-tuberculosis-free-status-for-england-2018-review

Share:

Related posts

Loading...

Which is the best test for bovine TB?

October 14, 2021
The current ‘test and cull’ approach to control of bovine TB does not provide farmers and their vets with effective tools to help prevent and manage the disease

Which is the best test for bovine TB?

October 14, 2021
The current ‘test and cull’ approach to control of bovine TB does not provide farmers and their vets with effective...
Johne's Disease testing service

Heartbreak and hope – the story of a new diagnostic for bovine TB

June 30, 2021
Former dairy farmer Jonnie Yewdall joined vets, farmers and others to discuss a new hope of ending the bTB heartache at an Agri-TechE hosted webinar.
Johne's Disease testing service

Heartbreak and hope – the story of a new diagnostic for bovine TB

June 30, 2021
Former dairy farmer Jonnie Yewdall joined vets, farmers and others to discuss a new hope of ending the bTB heartache...
David Christensen

Actiphage to offer greater decision support in the fight against Bovine TB

May 14, 2021
“From an industry perspective bovine tuberculosis (bTB) is a huge problem – the disease continues to move across the UK, and we don’t appear to be getting on top of it. We need many more tools in the toolbox in...
David Christensen

Actiphage to offer greater decision support in the fight against Bovine TB

May 14, 2021
“From an industry perspective bovine tuberculosis (bTB) is a huge problem – the disease continues to move across the UK,...
Cow on Lammas Land Bovine TB eradication

BVA advocates One Health approach to Bovine TB eradication

August 4, 2020
Allowing farmers with Official Tuberculosis Free (OTF) status to use APHA approved but currently un-validated tests for Bovine TB (bTB) is one of the recommendations of the British Veterinary Association (BVA) in its recent policy statement. PBD Biotech, developers of...
Cow on Lammas Land Bovine TB eradication

BVA advocates One Health approach to Bovine TB eradication

August 4, 2020
Allowing farmers with Official Tuberculosis Free (OTF) status to use APHA approved but currently un-validated tests for Bovine TB (bTB)...
1 2 … 5 Next »

developers of phage-based diagnostics

Contact Us

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

More reasons to invest in better diagnostics for #tuberculosis 1.6 million preventable deaths and increased pressure on the few treatments available. #EndTB

Read More
PBD Biotech

Delighted Dr Marie Roskrow is the new Chair @PBDBiotech to support development of our rapid TB diagnostic. A physician-scientist she brings expertise from @KinomicaLtd @ImevaX along with Patrys Limited, METALINEAR LIMITED, ArcticZymes Technologies

Read More
PBD Biotech

Testing 4 tuberculosis gained renewed attention in 2022 reports @360DxNews Highlighting $30m funding @UNITAID for @FINDdx also @PBDBiotech gaining $2.9M for its blood-based test to predict which individuals with latent TB will progress to active disease

Read More